Biological Agents Bioterrorims Preparedness
image of a smallpox vaccine vial


<<BACK

General Information

Illinois Department of Public Health Reportable Diseases

Information for Health Care Providers addressing Cutaneous Anthrax

CDC: Anthrax Q and A: Exposure

CDC: Preventive Therapy

CDC: Clinical Anthrax - PDF

Anthrax as a Biological Weapon, 2002 Journal of the American Medical Association

Diagnosis



CDC: Anthrax Q and A: Signs and Symptoms

CDC: Fact Sheet: Anthrax Information for Health Care Providers

CDC: Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax

CDC: Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax

Distinguishing Between Influenza-like Illness and Early Inhalation Anthrax

Surveillance

Bioterrorism-Related Inhalation Anthrax: The First 10 Cases Reported in the United States,
National Center for Infectious Diseases and the Centers for Disease Control and Prevention

Treatment

CDC: Patient Information:

CDC: Patient Information: Ciprofloxacin

CDC: Patient Information: Doxycycline

CDC: Patient Information: Amoxicillin

CDC: Community-Based Mass Prophylaxis

Liquid Ciprofloxacin for infants and children exposed to a disease - PDF [Video]

Liquid Doxycycline for infants and children exposed to a disease - PDF [Video]